Spectrum of various CNS inflammatory demyelination diseases following COVID-19 vaccinations.

Manish SalunkheKamlesh TayadeMegha PriyadarshiVinay GoelIsha GulatiAjay GargRohit BhatiaM V Padma Srivastava

Published in: Acta neurologica Belgica (2023)

Although a rare event, awareness regarding potential demyelinating episodes post-COVID-19 vaccination can help in early diagnosis. The presence of increased MOG-IgG antibodies with temporal association in post-COVID vaccine patients raises a possibility of an immunogenic phenomenon leading to demyelinating disorders.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
newly diagnosed
ejection fraction
respiratory syndrome coronavirus
prognostic factors
oxidative stress
blood brain barrier
patient reported outcomes
risk assessment